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                                               1.INTRODUCTION: 
Infertility is the inability of a couple to achieve pregnancy over an average 
period of one year (in a woman under 35 years of age) or 6 months (in a woman 
above 35 years of age) despite adequate, regular (3-4 times per 
week),unprotected sexual intercourse . Infertility may also be referred to as the 
inability to carry a pregnancy to the delivery of a live baby. Infertility can be 
due to the woman, the man, or both; primary or secondary. In primary 
infertility, the couples have never been able to conceive; while in secondary 
infertility there is difficulty in conceiving after having conceived (either carried 
the pregnancy to term or had a miscarriage).(1,3) 
The World Health Organization (WHO) has defined infertility as a failure to 
conceive over 12 months of exposure (which is a good practical guide to 
management), and leaves a longer term residual incidence of infertility of 10–
15%.However, the chance to conceive is reduced almost twofold after the age 
of 35 years.1) Epidemiological data suggest that approximately 80 million 
people worldwide are infertile. WHO indicates the highest incidence in some 
regions of Central Africa where the infertility rate may reach 50%, compared to 
20% in the Eastern Mediterranean region, and 11% in the developed world. The 
WHO estimates the overall prevalence of primary infertility in India to be 
between 3.9 and 16.8 %.(1,2,6) 
Infertility  has a direct impact on both psychological well-being and  social 
status of women all over the world. A WHO task force revealed that tubal factor 
accounted for 36%, ovulatory factor for 33%, endometriosis 6%, and no 
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demonstrable causes in 40% of cases.4A similar distribution was found in Asia, 
Latin America, and the Middle East.In Africa, most of the women were infertile 
due to tubal factor.(4,5,7) The risk factors for infertility can be classified into: 
genital, endocrinal, developmental and general factors. Pelvic inflammatory 
disease (PID) due to sexually transmitted diseases, unsafe abortion, or puerperal 
infection is the main cause of tubal infertility mainly caused by chlamydial 
infection.6Polycystic ovarian syndrome (PCOS) is the most commonest cause of 
anovulatory infertility.10 
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2. HYPOTHESIS AND JUSTIFICATION 
According to review of literature, 80 million people worldwide are infertile (10-
15%) and about two-third of infertility cases are caused exclusively by female 
factors.10 This study helps to identify and quantify the causes for female 
infertility and to calculate the  risk percentages, among the patients presenting 
to the out patient department in a tertiary health care centre. 
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3.AIMS AND OBJECTIVES 
1.  To estimate the prevalence of causes of female infertility. 
2.  To study the different factors responsible for female  infertility. 
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4.REVIEW OF LITERATURE 
Anatomy, Physiology and Reproductive Endocrinology in the Female  
Ovarian cyclicity upon which fertility depends is controlled by an elaborate 
neuroendocrine feedback system that involves the hypothalamus, pituitaries and 
ovaries. 
The hypothalamus is a part of brain which is a small neural structure located at 
the base of the brain above the optic chiasma and below the third ventricle. 
Hypothalamus is divided into three zones- the periventricular, medial and lateral 
zones, each of which is further subdivided. The hypothalamus interacts with 
many regions of the brain through various pathways that form feedback loops.11 
The major hormones secreted by hypothalamus are the pituitary releasing 
factors : 
• Gonadotrophin-releasing hormone(GnRH), that helps in the secretion of  
follicle stimulating hormone(FSH) and luteinizing hormone(LH). Also called 
luteinizing hormone-releasing hormone(LHRH), GnRH is a decapeptide 
produced by neurons in the arcuate nucleus of the hypothalamus. GnRH is a 
unique releasing hormone as it must be produced and secreted in a pulsatile 
fashion maintain its function, and its pulsatile release influences the release of 
both gonadotrophins. This pulsatility is necessary as GnRH has very short half-
life(2-4 minutes) as a result of rapid proteolytic cleavage. The frequency and 
amplitude of GnRH secretion varies throughout the menstrual cycle, with 
frequent low  amplitude and in a pulsatile manner  in the follicular phase, which 
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increase in the late follicular phase, and decrease in the luteal phase. These 
variations in amplitude and frequency are directly responsible for varying 
proportions of gonadotrophin secretion from the pituitary.12 
• Corticotropin-releasing factor(CRF), that controls the release of 
adrenocorticotropic hormone(ACTH). 
• Growth hormone releasing hormone-releasing hormone(GHRH), which 
controls the release of growth hormone(GH). 
• Thyrotropin-releasing hormone(TRH), which regulates the release of 
thyroid stimulating hormone(TSH). 
The pituitary is divided into three  lobes: anterior, intermediate and posterior. 
Embryologically, the larger anterior pituitary(adenohypophysis, pars distalis) is 
derived from Rathke’s pouch, an outpouching of the oral cavity. It is quite 
different from the smaller posterior pituitary(neurohypophysis, infundibular 
bulb), which is derived from a continuous extension of magnocellular neuronal 
axons, which terminate in the infundibular bulb. The adult pituitary gland 
weighs 0.5gm, measures 10 x 13 x 6mm and occupies a cavity in the sphenoid 
bone, the sellaturcica. 
The anterior pituitary is responsible for the production of FSH, LH, TSH, 
ACTH, GH and prolactin. The gonadotrophin; FSH and LH, are produced by 
the gonadotrophs, which are situated diffusely throughout the adenohypophysis 
and are responsible for ovarian steroid secretion and follicle stimulation. 
Structurally, FSH and LH, are both glycoproteins with two amino acid chains- 
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identical α subunits and differing β subunits. The synthesis of the β subunits is 
the rate limiting step in gonadotrophin biosynthesis.11 Prolactin is a 198 amino 
acid polypeptide secreted by the lactotrophs, and is the primary  factor 
responsible for the synthesis and secretion of breast milk 
Endogenous opioids, three structurally similar families of naturally occurring 
substances produced by the CNS, are the endorphins, encephalins and 
dysmorphins. They play a vital role in the regulation of hypothalamic-pituitary 
function, and  inhibitsGnRH release. 
Hypothalamic-pituitary-ovarian feedback mechanisms may be divided into four 
stages: 
• FSH and LH secretion during the early follicular phase in response to 
low serum oestradiol(E2) and progesterone levels, after the preceding corpus 
luteum cease to function (negative feedback). 
• Reduced FSH secretion from midfollicular to late follicular phase in 
response to rising E2 production in maturing follicles (negative feedback). 
• Midcycle LH surge initiating ovulation and corpus luteum function, in 
response to preovulatory E2 (positive feedback). 
• Decreased FSH and LH secretion during the luteal phase in response to 
E2 and progesterone secretion by the corpus luteum (negative feedback).13 
 
 
8Ovary 
The ovaries are are unique organs in that their primary function is 
gametogenesis, and all their endocrine activities (namely sex hormone 
production) subserve this function. The ovarian cycle is designed to ensure that 
mature female gametes (oocytes) are produced in good condition in an 
appropriate number at ovulation so that they are available for fertilization by 
sperm, thus ensuring survival of the species. 
Figure 1 : Anatomy of ovary 
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Anatomy  
The mature ovaries are paired organs, 4 x 3 x 1cm in size, situated in the 
abdominal cavity weighing approximately 8 grams each. The ovaries are 
suspended between the lateral pelvic wall and the uterus,  laterally by the 
infundibulopelvic ligament  and the medially by uteroovarian ligament. Inferior 
attachment of  the hilar surface is  to the broad ligament by the mesovarium and 
through this run blood vessels and nerves. Each ovary consists of a large outer 
cortex containing germ cells and small central medulla composed mainly of 
stromal cells. A single layer of cuboidal epithelium covers each ovary, which is 
continuous with the mesovarium. The ovary receives its blood supply from the 
ovarian artery. 
During each menstrual cycle, the ovaries produce a single dominant follicle 
which is responsible for ovulation. After ovulation the dominant follicle 
becomes corpus luteum, and  secretes large amounts of progesterone during the 
secretary phase of the menstrual cycle. Oestradiol and progesterone acts on the 
endometrium of the uterus and prepare it for the implantation of  embryo.14 
Embryonic development: 
At approximately 5 weeks of fetal life, primordial germ cells usually migrates 
from the yolk sac to the genital ridges. There they undergo rapid mitotic 
division and give rise to oogonia, which continue to divide and reach a 
maximum of 6 to 7 million by the 20th week of fetal life. During the later half 
of fetal life, these primordial follicles undergo maturation, arrest and atresia so 
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that at birth, only one to two million follicles are present. This number further 
decrease by 80 to 90% so that at puberty, only 300,000 follicles remain, of 
which only 300 to 400 are destined to ovulate. The developing oogonia enter 
meiotic prophase 1 at about 8 weeks of life, when they are known as primary 
oocytes. Only the group of  oocytes which enter meiosis will survive the wave 
of atresia that sweeps the fetal ovary; these oocytes remain arrested in  leptotene 
stage of prophase till ovulation, when meiosis resumes.15 
Follicular development: 
The dynamic process of folliculogenesis happens mainly within the ovarian 
cortex  and it consists of four major developmental events:  
i.    recruitment of  primordial follicle; 
ii.    development of  preantral follicle; 
      iii.         selection and growth of the preovulatory follicle;  
iv .         ovulation or death by follicular atresia. 
Folliculogenesis is divided into 2  phases, the preantral (gonadotrophin-
independent ) and  antral phase (gonadotrophin-dependent ). The preantral 
phase occurs when the oocyte grows and differentiates which is controlled by 
autocrine/paracrine mechanisms through locally produced growth factors . In  
antral phase (graafian phase ) there will be  increase in the size of the follicle 
itself and is regulated by Follicular stimulating hormone and Leutinising 
hormone and also by growth factors. 
11 
 
Chronology: 
In each menstrual cycle, from the primordial follicle which has undergone 
recruitment almost 1 year back  develops in to a dominant follicle and ovulates. 
The class 1 phase or preantral phase is divided into 3 major stages: the 
primordial follicle, primary follicle, and secondary follicle stages. About 290 
days or about 10 regular menstrual cycles required for the development of a 
primordial to a full grown secondary follicle.16 
Primordial follicle: 
Primordial follicles or oocytes are  the essential reproductive cells of the ovary 
as they, cause all menstrual cycles by giveing rise to all the dominant follicles. 
The primordial follicle to primary follicle transition is otherwise known as 
recruitment occurs when the arrested promodial follicle enters in to the group of 
growing follicles. Histologically a primordial follicle consists of a small 
primary oocyte (approximately 25µm in diameter) which has gort arrested in 
the late diplotene stage of meiosis. It also contains a single layer of flattened or 
squamous granulosa cells and a basal laminal layer. As all oocytes are formed 
in intrauterine life, they are present in ovaries at birth. Hence the number of 
eggs or primordial follicles in a women’s ovaries constitutes her ovarian 
reserves. 
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Figure 2 : Histology of ovary  
 
 
In the fetus some primordial follicles gets recruited and soon after their 
formation it grows.  Primordial follicles gets recruited at a  regular rate during  
first 3 decades of a women’s life. On the other hand, when the Ovatian Reserve 
reaches a significant number of around 25000 at about 40 years of age, the 
propotion of loss of primordial follicles doubles. A decrease in fecundity 
accompanies this increased loss of OR. The primary to secondary transition is 
highly influenced by high concentration of Follicular stimulating hormone in 
plasma. 
The histological hallmarks of recruitment are  transformation of  cell  from 
squamous to cuboidal and the acquirement of mitotic potential in  granulosa 
cells, which is followed by activation of gene and oocyte growth . Therefore the 
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primary mechanism that control recruitment consists of  the granulosa cells and 
the oocyte is a responding tissue to the primary activation event.5 Initial 
recruitment is gonadotropin independent, but shortly thereafter FSH helps in 
control of differentiation and growth, and subsequent steps are gonadotropin 
dependent. Mullerian inhibiting substance (MIS) has been found to inhibit 
recruitment.6Inspite of its clinical importance, we know nothing about how 
recruitment is controlled in women.17 
Primary follicle :  
A primary follicle has  more granulosa cells that are cuboidal in shape which 
are placed in a single layer around a oocyte. The developmental events in 
primary follicle consists of  expression  of FSH receptor, growth and oocyte 
differentiation.The oocyte increases in width of about 25 µm to 120 µm during 
the preantral period. 
Occurrence  of the gap junctions linking the oocyte and granulosa cells is an 
important event in primary follicle development. Gap junctions are intercellular 
channels composed of connexins (a type of protein) that connects adjacent cells 
helps in the transport of various ions, metabolites and molecules like cAMP and 
calcium.17 
When the oocyte completes its growth during the preantral folliculogenesis, it  
gets  capacity to resume meiosis. Rarely the full grown oocytes  resume meiosis 
during the folliculogenesis. It  shows that there exists a meiotic inhibition 
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system. Eventhough the nature of this mechanism is unclear, it is evident that 
cAMP is involved. 
Secondary follicle : 
Secondary follicle development is differentiated by the accumulation of 
increased numbers of granulosa cells, a change from simple cuboidal cells to 
stratified cells or pseudostratified columnar epithelial cells, and the acquisition 
of the theca. The theca develops very early in folliculogenesis. 2 primary theca 
cell layers starts appearing, 
  inner theca interna gives rise  to theca interstitial cells. 
  outer theca externa that gives rise to smooth muscle cells. 
 It  is  accompanied by the formation of several small blood vessels transporting 
nutrition and hormones in to the follicle  and waste and secretory products out 
from the developing follicle. 
At the end of the folliculogenesis (preantral phase), a mature secondary follicle 
contains five distinct structures: a fully grown oocyte bounded by a 
zonapellucida, approximately nine layers of granulosa cells, a basal laminar 
layer, a theca interna, a theca externa and capillaries within the theca tissue.18 
Graafianfollicle : 
A fully grown graffian follicle is consists of  a cavity or antrum containing 
follicular liquid  called liquor folliculi. This liquor folliculi is the medium in 
which granulosa cells and oocyte rests through which molecules gets 
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transported. Graafian follicle growth and development can be grossly divided 
into four stages according to their size. Each dominant follicle has the potential 
to complete transformation from the small (1-6mm), medium (7-11mm), large 
(12-17mm), to the pre ovulatory state (18-23mm). An atretic follicle does not 
develop beyond the small to medium stage (1-10mm). 
OVULATORY FOLLICLE AND OVULATION 
Increase in size of follicle occurs due an increase in amount of follicular fluid 
with regression of the theca cells and as a result, the layer of granulose cells 
becomes stretched and thin. The oocyte is attached to the granulosa cells by a 
thin stalk of cell. The follicle now bulges from the surface of granulose cells by 
a thin stalk of cells, a distinct stigma is formed with increased blood vessels in 
the stigma. There is rupture at base of the stigma releasing gently the follicular 
fluid and cumulus mass of cells enclosing the oocyte. A small amount of 
bleeding usually occurs but it soon ceases as the vessels in the region of stigma 
constrict. The rupture is infrequently accompanied with pain. This mid cycle 
pain is known as Mittel schmerz occurs infrequently. Following the release of 
ovum, residual part of follicle wall collapses in to the empty space and a clot is 
formed. Unless fertilized, the ovum does not survive more than 24 hours. The 
post ovulatory follicle is comprised of a fibrin core surrounded by several layers 
of granulose cells enclosed within a fibrous  theca capsule. 
There is as yet no unanimous agreement as to the process of follicular rupture. 
Two hypothesis have been proposed which may explain the process of follicular 
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rupture. One theory proposes that muscular contraction in ovary contribute, and 
the second theory proposes that enzymatic changes within the follicle cause 
dissolution of the follicle wall and induces follicular rupture. In a 28 day 
menstrual cycle , ovulation occurs around day 14. In irregular cycles it is the 
follicular phase which varies, secretory or postovulatory phase remains 
constant. Stress, emotional factors, violent physical exercise, behavioural and 
endocrine factors can disturb or modify the timing of ovulation. The hormone 
assays for detecting plasma or urinary estradiol levels can correctly detect the 
time of ovulation. It occurs 24-34 hours after peak level of estradiol is reached. 
The basal body temperature rises following ovulation due to increase in plasma 
levels of progesterone.19 
FORMATION OF CORPUS LUTEUM AND LUTEOLYSIS 
The corpus luteum forms after ovulation with the fibrosis of the fibrin core and 
some of the theca cells becoming incorporated within the developing corpus 
luteum. The process of lutenization begins just before ovulation. There is an 
increase in level of 17 alpha hydroxyl progesterone at midcycle soon after the 
beginning of the LH surge. The corpus luteum has a limited life span. If there is 
no implantation of the fertilized ovum, then it undergoes luteolysis. 
Two types of cells are identified in the corpus luteum, theca and granulose 
lutein cells. There may possibly be another cell type, the K cells. The formation 
of luteal body encompasses several tages like proliferation, hyperaemia, and 
vascularisation. Granulose lutein cells undergo hypertrophy, accumulate lipid 
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droplets, and are shoewn to have granules containing lipofuscin, ehich gives the 
characteristic yellow colour to the luteal body. The cells contain distinct golgi 
complex, numerous vesicles, agranular endoplasmic reticulum and extracellular 
canaliculi. These extra cellular canaliculi function as a system to transport 
steroid from the cells to capillaries. On days 6-8 post ovulation, the blood 
vessels reach the centre of the luteal mass and steroid secretion reaches peak 
levels. The corpus luteum , by this time , reaches its stage of maximum 
development. This stage is followed by declining steroid levels unless 
blastocyst implantation occurs. The fully formed corpus luteum releases large 
amount of 17-beta estradiol and progesterone. From about datys 7-8 post 
ovulation , luteal regression is initiated. Degeneration of the cells occurs. The 
cells undergo lipolysis, atropy and bloodflow declines. The corpus albicans is 
formed which is composed of collagen fibres and few cells. LH is luteotrophic 
in women.20 
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Figure 3 : Histology of Graffian follicle 
 
Figure 4 : histology of Corpus luteum 
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ENDOMETRIAL CYCLE 
The most obvious manifestation of a normal menstrual cycle is the presence of 
regular menstrual periods. Every month the uterus prepares for a pregnancy by 
generating a thick bed of secretory endometrium for the implantation. Due to 
failure of fertilization of the oocytes or implantation, the menses starts. Hence, 
menstruation is described as “weeping of a disappointed uterus for a baby”.  
       The endometrium is the superficial epithelium, which lies in the uterine 
cavity. It has two principle components, the glandular epithelium and 
supporting stromal cells. During the menstrual cycle the epithelium 
differentiates to form three functional zones. The basalis spongiosum and 
stratum compactum.21 
         The endometrial events can be divided into three phases. 
1. Menstrual phase 
2. Proliferative phase 
3. Secretory phase 
MENSTRUAL PHASE 
The beginning of each endometrial cycle is characterized by complete shedding 
of the spongiosum and stratum compactum layers (day 1) during menstruation 
which lasts for 3 to 5 days. The fall in plasma progesterone and oestrogen levels 
due to degeneration of corpus luteum leads to withdrawal of hormonal support 
of the endometrium, which causes menstruation. The first event is profound 
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vasoconstriction of uterine blood vessels, which leads to decreased supply of of 
oxygen and nutrients to endometrium. Disintegration starts in the entire lining 
except the basalis layer that will regenerate the endometrium in the next cycle. 
After the initial period of vasoconstriction, the endometrial arteriole dilates 
resulting in hemorrhage through vascular capillary walls. The menstrual flow 
consists of blood mixed with endometrial debris and mucus. 
 
PROLIFERATIVE PHASE 
Menstrual flow ceases and endometrium begins to thicken as it regenerates from 
the basalis layer. The period of growth lasts for 10 days or so between cessation 
of menstruation and occurrence of ovulation. The ovarian follicular phase 
corresponds to menstrual proliferation phase of endometrial cycle. The uterine 
changes during the menstrual cycle are caused by the changes in plasma 
concentration of oestrogen and progesterone. During proliferative phase a rising 
plasma oestrogen level will lead to reconstruction and growth of endometrium. 
Both glandular and stromal component achieve proliferation which peaks at 8 to 
10 days of cycle and corresponds to peak oestrogen level. During this phase, the 
endometrium grows from approximately 0.5 mm in height. 
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SECRETORY PHASE 
Soon after ovulation the endometrium begins to secrete various substances and 
the part of the menstrual cycle between ovulation and the onset of next 
menstruation is called secretory phase. The circulatory progesterone which is 
secreted  by the corpus luteum after ovulation acts upon the oestrogen primed 
endometrium to convert it to actively secreting tissue. Its glands become coiled 
and filled with glycogen. The blood vessels become more numerous and 
densely coiled. Various enzymes are secreted in the glands and connective 
tissue. These changes are essential to make the endometrium a hospitable 
environment for an embryo.22          
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Figure 5 : Physiology of menstruation 
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Uterus : 
 The uterus is a fibro muscular organ usually divided into an upper corpus 
or body and lower cervix. The size and configuration of the uterus undergoes 
many changes throughout life, at birth the cervix and the uterus are 
approximately the same size and during reproductive years the corpus grows to 
2 to 3 times the size of the cervix. It measures approximately 7x5x3cm, with a 
volume of 3 to 8 ml. After menopause it involutes and becomes atrophic. The 
endometrial cavity is triangular in shape and represents the mucosal surface of 
the corpus. The ultimate function of the uterus, to house and support the 
conceptus, is dependent on the cyclic alterations in the endometrium. The 
myometrium consists of interlacing smooth muscle fibres, and the serosa is the 
outermost layer, formed by the peritoneum. The blood supply is by the uterine 
artery, which anastomosis with the ovarian and vaginal arteries.23 
CERVIX AND VAGINA 
The cervix has lesser muscle cells compared to the myometrium. These are 
dispressed in a ground substance containing glycosaminoglycans and collagen 
fibrils. The collagen synthesized by the connective tissue is arranged in an 
orderly fashion. Functions of the cervix are : 
 To help the passage of sperm towards the uterus 
 To prevent expulsion of fetus during pregnancy  
 To allow the passage of fetus at parturition 
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At term, the cervix undergoes significant structural and functional changes 
referred to as ‘ripening’ of the cervix. This involves changes in the structure og 
the tissue matrix with the loss of collagen and increase in the 
glycosaminoglycans (CAG) content which helps in loosening of collagen 
fibrils. Estrogen and progesterone determine the nature of secretion from the 
endocervical glands and the cervical ripening in preparation for labour. 
The vagina consists of three layers: mucous, muscularis ans fibrous sheeth. The 
mucosal layer shows several folds lined by stratified squamous epithelium. The 
epithelium contains high amount of glycogen. Under estrogen dominance 
glycogen synthesis is increased. The levels of circulating estrogen and 
progesterone also influence the nature of vaginal fluid. When the estrogen level 
in blood is high, the vaginal fluid becomes acidic due to the action of 
Doderlein’s bacilli on the carbohydrates in the vaginal epithelium.24 
Fallopian tube: 
The oviduct forms an important part of the reproductive system and links the 
uterine cornua to the ovaries. Its functions include ovum pickup, the mechanical 
transport of gamates, provision of a physical environment for conception and 
physiologic sustenance of the early conceptus. 
The fallopian tube are paired hollow structures approximately 6 to 15 cm long 
(average 11cm). their caudal ends anastomose with the uterus and their 
proximal or cephalic ends open freely in the peritoneal cavity. The mesosalpinx 
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formed by the two sheets of abdominal serosa, encloses the tube, and within it 
run muscle fibres, supporting ligaments, nerves, blood vessels and lymphatics. 
Depending on the anatomic location , the amount of circular smooth muscles of 
the wall, the degree of folding and cellular composition of the mucosa, as well 
as autonomic innervation, its possible to distinguish four distinct segments of 
the tube. From cephalic to caudal these are fimbria, ampulla, isthmus and 
interstitial parts of the tube. The tubal mucosa is ciliated columnar epithelium 
with predominance of ciliated and secretory cells at the fimbrial end, which 
decrease in number as the uterus is approached. 
The fallopian tube is supplied by a rich anastomosing network of vessels fed 
from both the uterine artery and the tubal branch of the ovarian artery, and the 
innervation is also dual, from the uterovaginal and ovarian plexuses. 
Oocyte capture occurs through the coordinated efforts of the tube and ovary. 
Oocytes reside in the ampulla for about 72 hours, during which time 
fertilization occurs. Through the exact in vivo nutritional and metabolic 
conditions are not known, an iso osmotic balanced solution of amino acids, 
pyruvate, lactate and albumin are required to support the pre embryo to 
blastocyst stage. Ovum transport in the tube occurs through the integrated 
activities of the muscular myosalpinx and cilia. The isthmus serves as the 
transitional area between the tube and the uterus, and has both permissive and 
restrictive roles in sperm and ovum transport.23 
26
Figure-6:Female reproductive system
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FEMALE INFERTILITY 
Failure to conceive within a year , when a couple is staying together and 
cohabiting with an idea of having a pregnancy is labelled as infertility, it may be 
primary when there has been no conception at all or secondary when a woman 
has had prior conception and now fails to conceive. 
Incidence: the incidence of fertility in any community varies between 8 - 15%, 
though the exact estimation of the same is difficult. 
Of the couples staying together and not using any contraception , approximately 
60% conceive in 6 months, 75% in 9 months and 80% in 1 year. Another 5-10% 
may conceive subsequent years.25 
MAJOR CAUSES OF INFERTILITY 
Several factors influence the process of conception, the failure of which can be 
due to defects in any of these. For normal conception to occur, there must be  
 Normal spermatogenesis 
 Semen deposition in the vagina at the time of ovulation 
 Normal ovulation 
 Functionally normal fallopian tubes able to pick up the ovum 
 Normal uterine cavity for the implantation as well as the continuation of 
pregnancy  
 Cervical secretion which are under cyclic hormonal control and are normal to 
allow passage of the sperms  
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 There should be no immunological incompatibility. 
The male partner alone may be at fault in approximately one-third of the cases, 
the female partner alone in another third and in the remaining thirdboth may be 
at fault some of the defects may be remediable.26 
NORMAL REPRODUCTIVE EFFICIENCY 
Human reproduction is not efficient. In presumably fertile couples, a maximal 
monthly fecundity rate of 20-30 % is demonstrated (5-7). Likewise, pregnancy 
loss is common. This has been demonstrated as early as 1949, when Hertig and 
Rock  reported in their now classic studies in which early embryos were 
recovered from 107 women who had intercourse at the estimated time of 
ovulation, prior to undergoing hysterectomy (8). One-third of the embryos was 
deemed to be abnormal; however, this was limited to the morphologic 
assessment of the embryos. Forty to sixty % of conceptuses (as defined by a 
positive HCG value) fail to achieve 12 weeks of gestation, with the majority of 
losses occurring prior to the recognition of pregnancy by the mother (5-7). 
Miscarriage rates appear to be affected most by the maternal age, with natural 
conception cycles resulting in losses for 7-15% of women less than 30 years, 8-
21 % for ages 30-34, 17-28 % for ages 35-39 and 34-52 % for ages 40 and 
above will(9-11).26 
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INDICATION FOR EVALUATION 
Formal evaluation of infertility is  generally indicated in women attempting 
pregnancy who fail to conceive after a year or more of regular, unprotected 
intercourse as 85% of couples will achieve pregnancy with out assistance within 
one year of time. Earlier evaluation and treatment is indicated in women with 
1. Age more than 35 years 
2. H/O oligomenorrhea/ amenorrhea 
3. Known case of uterine/tubal disease, endometriosis, or diminished 
ovarian reserve 
4. A partner who is known to be or suspected to be sub fertile. 
The  extent of evaluation should take into account the couple’s wishes, both the 
partner’s age, the duration of infertility, and unique features of the medical 
history and physical examination.   
EVALUATION 
• The couple must be considered as a single unit as each partner 
contributes a share to the infertility potential of the couple . Initial consultation 
with the infertile couple should include a complete medical and menstrual 
history  including a review of lifestyle and social habits, physical examination, 
and pre conception counselling. The evaluation of female infertility assesses 
each component of   reproductive physiology to identify  an abnormality: 
cervix, uterus, the endometrium, the ovarian function, the fallopian tubes, and 
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the peritoneum. The initial screening evaluation of the male partner should 
include, at a minimum, a reproductive history and two properly performed 
semen analysis. A careful h/o history and physical evaluation of each partner 
can direct further investigation. Evaluation of both partners should be initiated 
simultaneously as it is imperative that infertility is approached as a couple 
disorder. 27 
HISTORY 
Couples attending their first visit to the reproductive center are asked to 
complete  an extensive self assessment questionnaire prior to their visit. The 
importance of this questionnaire is to ascertain relevant medical and surgical 
history. In the female partner, the menstrual history, outcome of previous 
pregnancies, length of infertility, sexually transmitted diseases, outcome of 
previous surgeries, as well as prior infertility investigation and treatment are 
critical issues. Specifically, it is necessary to carefully review any prior 
treatment attempts, including evidence of ovulation with clomid, number of 
follicles developed in response to gonadotropin  therapy, amount of drug  
utilized, peak estradiol levels, number of oocytes produced with ART, and 
embryo progression.  
It is important to provide some privacy during history taking to allow the patient  
and the partner to disclose  any relevant that she or he may be reluctant to 
discuss in front of her or his partner. Such sensitive issues could include a 
history of sexually transmitted infections, coital difficulties, prior pregnancies 
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and/or elective terminations, and  so on. The regularity, length, and frequency 
of the women’s menstrual cycle, as well as associated symptoms such as pain 
should be documented. A history of oligomenorrhea/amenorrhea and signs of 
androgen excess may be suggestive of  polycystic ovary syndrome. Complaints 
of chronic pelvic pain, dysmenorrhoea or dyspariunia may suggest the presence 
of  endometriosis. Episodes of sexually transmitted disease, a history  of prior 
pelvic/abdominal surgery, or a ruptured appendix may indicate significant 
pelvic adhesions tubal damage or obstruction. The history of previous abnormal 
pap smears and any subsequent  treatment should be elicited. Cervical factors 
account for a very  small percent (3-5%) of all infertility cases  and may be 
present in patients with a history of multiple D&C, cone biopsy, cryosurgery, or 
LEEP. Prior surgical procedures of the cervix may also result  in the decreased  
cervical mucous production and cervical stenosis. 
                  It is also important to obtain a detailed sexual history in terms  
methods of contraception, the frequency   and timing of intercourse, ability to 
reach orgasm, and incidents of separation. The couple should be questioned 
about the use of coital lubricants and postcoitaldouching  because both are 
potentially spermicidal.  
Other relevant aspect of the medical history includes: current medications and 
allergies; occupation and use of tobacco, alcohol, and other drugs; family 
history of  birth defects, premature ovarian defects, pre mature ovarian failure, 
mental retardation or reproductive failure; symptoms of thyroid dysfunction, 
galactorrhea, hirsutism, pelvic pain, and dyspareunia. 
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              Nutritional status, marked weight gain or loss, or intensive physical 
activity may signal ovulation dysfunction. Often overlooked while eliciting a 
history are the social and lifestyle factors that can negatively impact fertility. 
These modifiable factors need to be addressed as part of thorough assessment. 25 
PHYSICAL EXAMINATION 
A through physical examination along with pelvic examination should be 
undertaken and focused on the issues that could be relevant to fertility. Absence 
of secondary sexual characteristics should be noted, and stages of pubertal 
development could be relevant  in some patients by using Tanner’s scale. 
Scanty axillary and pubic hair may suggest testicular feminisation syndrome, 
which is due to androgen resistance. Such patients are genetically males and 
phenotypically females. The  abscence   of axillary and pubic hair accompanied 
by anosmia should  raise suspicion to Kallmann’s syndrome, which is due to 
congenital absence of the GnRH. Increased  facial or midline hair may be 
indicative of androgen excess  and highlight the possibility of polycystic  
ovarian syndrome or other relevant adrenal or ovarian disorders. 
It is important  to realize  that mild forms of  late onset of adrenal 
hyperplasia due  to 21-beta- hydroxylase deficiency  could be clinically 
indistinguishable from PCOS. This is due to the fact that partial enzyme 
deficiency is usually associated with normal cortisol and  mineralocorticoid 
levels  unlike the classical infantile type, which is characterized by  decreased 
cortisol levels and high mineralocorticoid activity. The presence of 
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acanthosisnigricans is a sign of insulin resistance and may be associated with 
PCOS, diabetes mellitus of thyroid dysfunction. Central obesity, buffalo neck, 
and moon faces may suggest Cushing’s syndrome, which could be associated 
with abdominal striae and other pathognomonic features. Turner’s  syndrome is 
characterized by  short stature, webbed  neck, shield chest, undeveloped breast  
and cubitus valgus. The thyroid gland should be evaluated and palpated and 
features of multinodulargoitre should be observed. Other features of thyroid 
should be noted ( thin hair, myxedema, skin texture, bradycardia or tachycardia,  
tremors, diarrhoea, weight loss, and exopholthalmos) . Both hypothyroidism or 
hyperthyroidism are associated with infertility. The former when present tends 
to be associated with some degree of hyperprolactinemia. 
Breast  examination for any evidence of galactorrhea should not be 
missed during the general examination. However. 50 % of women reporting 
galactorrhea have normal prolactin levels. Other signs of prolactinomas should 
be assessed (headache, anorexia, vomiting, and visual defects. Body mass index 
should be calculated if the patient is noted to be over or under weight. The BMI 
calculated by dividing the weight in the kilograms with the height meter 
squared, with the normal range  falling between 18.5 and 24.9 kg/meter square. 
The association between  obesity and ovulatory  dysfunction  is well 
documented. Women with increased BMI are encouraged to reduce weight, 
which may help in the resumption of ovulation spontaneously and increase 
responsiveness to fertility therapy. On contrary, severely underweight women 
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should be encouraged to increase their weight to within the normal range prior 
to ovulation induction to decrease the risk of a low birth weight baby. 27 
The importance of pelvic examination can never be over emphasized and should 
be performed at initial visit. Unfortunately, with increasing use of ultrasound, 
many practitioners are reluctant in performing complete pelvic examination, 
which should not be case. Congenital  malformations of the vaginal tract should 
be screened for such as double cervices and vaginal septum. Congenital absence 
of the vagina (Mayer-Rokitansky-Kuster-Hauser syndrome) remains to be most 
frequent cause of primary amenorrhea. 
Speculum examination and thorough evaluation of the cervix should be 
performed. Cervical smear and Chlamydia screening  should be performed if 
not already done. Chlamydia infection is central in the pathogenesis of pelvic 
infection that may result in the development of tubal infertility, pelvic pain, and 
ectopic pregnancy.    Bimanual examination is helpful in determining the size, 
shape and mobility of the uterus. The adnexa are examined for the presence of 
ovarian endometriomas or cysts. Nodularity in the utero sacral ligaments on 
rectovaginal  examination suggests the presence of endometriosis. 
In summery, as outlined in the ASRM 2006 Practice comittee opinion, the h/o 
of the patient should include 
1. Gravidity, parity index, pregnancy outcome, and associated complications 
2. Age at menarche, characteristics of menstrual cycle  and onset/severity of 
dysmenorrhoea 
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3. Methods of contraception used and coital frequency 
4. Duration of infertility and results of any previous evaluation and 
treatment 
5. Past surgery, its indication, and outcome, previous hospitalizations, 
serious illness or injuries, pelvic inflammatory disease or exposure to 
STD and unusual childhood diseases. 
6.  Any Previous abnormal pap smears and subsequent treatment in the past 
7.  Current medications and allergies 
8.  Occupation and use of tobacco, alcohol other drugs 
9.  Family h/o birth defects, mental retardation or infertility 
10.  Symptoms of thyroid disease, pelvic or abdominal pain, galactorrhea, 
hirsutism, and dyspareunia. 
The physical examination should  note the patient’s weight and body mass 
index and identify any 
1. Thyroid enlargement, tenderness or nodule 
2. Breast secretions and their character  
3. Signs of excess androgen  
4. Pelvic or abdominal tenderness, organ enlargement, or mass 
5.  Vaginal or cervical abnormality, abnormal secretions, or discharge  
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6. Uterine size, shape, position and mobility 
7.  Adnexal mass or tenderness, and 
8. cul-de-sac mass, tenderness or nodularity. 26 
ASSESSMENT OF ANATOMICAL FACTORS 
TUBAL FACTOR 
The patency of fallopian tubes can be tested by several tests which are 
carried out in the immediate post menstrual phase of the cycle. This timing 
reduces (i) false positive test (ii) decreases the risk of accidental embolism and 
endometriosis and (iii) avoids accidental disturbance of undiagnosed pregnancy. 
Tubal insufflating carbon-dioxide gas through the cervix in to the uterine cavity 
and tubes. The insufflation cannula is made air tight and is attached to a 
kymograph. Gas is slowly passed at a rate of 60ml/min. as it flows, to begin 
with there is a rise in pressure to about 100mm of Hg which falls to 70-80 mm 
of Hg as the free flow of gas is established. A peristaltic activity is also 
recorded on the kymograph. Patency is also judged by simultaneously 
auscultating over the midinguinal point where a gurgling sound is heard. A rise 
of pressure up to 200 mm of Hg indicates bilateral tubal block. The test is now 
abandoned. 
This test has a very high false negative and a very high false positive 
rate. It is not a popular test and it is not a routine in all centres.some times this 
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test may help in establishing tubal patency by breaking flimsy adhesions due to 
pressure of gas.28 
HYSTEROSALPINGOGRAPHY 
In this test, instead of gas a radioopaque dye is injected through the 
canula under fluoroscopic control and X-ray films are taken. It helps in the 
identification of  uterine abnormalities and exact site of tubal block if any. False 
negative rate is low, the block being missed in 5% of cases. Over diagnosis of 
tubal block can be there in 10-20% of the cases. 
HYSTEROSALPINGOGRAPHY 
This is a new test which can be done instead of hystero-salpingography. 
Normal saline is pushed in the uterine cavity either through a paediatric Foleys 
catheter the bulb of which is inflatted  at the cervical or through the Rubins 
canul. Ultrasound is done to follow the fluid through the uterus and then 
through the tubes in to the peritoneal cavity. Any uterine polyps or 
malformation and tubal block can be diagnosed. There is no exposure to 
radiation. If patient fails to conceive for 6 months, despite tubal patency on 
HSG a laparoscopic evaluation is done.28 
LAPAROSCOPY 
It is done under general anaesthesia. After introducing a laparoscope, 
chromotubation is done by injecting methylene blue through the 
hysterosalpingogram cannula or foley’s catheter introduced in the uterine cavity 
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through the cervix. The dye can be seen through the laparoscope passing 
through the tubes and coming out of the fimbrial ends if the tubes are patent. 
Laparoscopy also helps in the diagnosis ofbicornuate or unicornuate uterus, 
peritoneal adhesions, endometriosis, pelvic tuberculosis, tubal kinks, and 
hydrosalpinx. The segment distal to the site of block and available tube length 
can also be evaluated. Currently only one method of tube testing is done 
depending on the availability of the facility present laparoscopy is gold stranded 
as it can obviate false positive test seen due to spasm of the uterine cornua 
during other tubal tests.  
UTERINE FACTOR 
Abnormalities of the uterus are uncommon causes for infertility. Failure 
of conception may result from local pathology resulting in inadequate 
preparation of the endometrium and defective implantation. 
Local pathology may be tubercular endometritis, moderate to severe uterine 
hypoplasia, myoma or asherman’s syndrome. A diagnosis of tubercular 
endometritis is made on endo metrial biopsy. 
Intra-uterine synechiae or submucous myomas can be diagnosed, by 
hysterosonography. The hysteroscopy is preferred mode of investigation for 
detecting intrauterine pathology and is fast becoming popular. It can offer 
treatment at the same sitting.it is routinely combined with laparoscopy which 
together help in detecting both intra and extra uterine pathology.29 
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CERVICAL FACTOR 
There may be an abnormal cervix, cervical infection or abnormal 
cervical secretion. These can be diagnosed on inspection and easily rectified. 
A post-coital test (Sim’s Hunyer’s): evaluates sperm penetration in vivo. The 
test is done at the time of ovulation. The women is called 4-8 hours after sexual 
intercourse, cervical mucus is collected from endocervical canal and examined 
under microscope. The number of motile sperms per high field are counted. If 
no sperms are identified , either coitus has not taken place or the husband is 
azoospermic or the whole discharge has leaked out. Identification of only dead 
sperm indicates cervical mucus hostility or infection. The couple needs to be 
investigated further for infection and immunological factors. If the number of 
live sperms is 15-20/high power field, it is an excellent or good test and 
indicates good cervical function. 
PERITONEAL FACTOR 
Adhesions (peritubal, perifimbrial, periovarian and omental) altering 
tubal function and ova pick up by the fimbriae and endometriosis are major 
peritoneal problems. Diagnostic laparoscopy is the best rocedure for evaluation 
of these factors. In 10-15% of couples, no abnormal factor may be detected.30 
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 IzatullaJumayev et al (2012) in the study of social correlates of female 
infertility in Uzbekistan, concluded, that 65.0%  of patients who had infertility 
were diagnosed to have anovulation. Tubal blockage was the next major cause 
for infertility in 23.3%, immunologic factors in 1.7%, and the remaining 10.0% 
of women were suffering unexplained infertility.31 
 Adamson et al (2011) in the study of  Prevalence& correlates of primary 
infertility among young women in Mysore, India, reported the mean age of the 
women was 25.9 yr which ranges from 16-30 year and the prevalence of 
primary infertility was 12.6 per cent.  HSV-2 seropositivity was the main factor 
associated with primary infertility.32 
 Cornillie, et al (1995) found in their study that the preventable risk factors for 
infertility were: PCOS: 18%, Endometriosis: 2.3%, genital infection: 10%, 
menstrual cycle irregularity,13.7%, history of previous surgical operations: 
5.2%.33 
 Friday EbhodagheOkonofua et al (2005) studied on the epidemiology of 
infertility in Nigeria with special references comparing the role of genital tract 
infections and sexual and reproductive risk factors, has concluded that there is a 
strong correlation between episodes of reproductive tract infection and 
infertility among women in Nigeria.34 
 In a study which was carried out in Aberdeen Fertility Centre from 1993-2006, 
the factors that affects couples infertility including age of male and female 
partner, year of first visit, diagnosis, duration and type of infertility were 
investigated. Of all participants, 26.9% were of age more than 35 years and 
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primary infertility was seen in 51.4%. The mean female age was 31.2 (5.2 SD) 
years. It was evident that there was a strong association between age of the 
female and the cause of female infertility. Most of the women over 35 years of 
age had unexplained infertility (26.6 versus 21.0%, p< 0.001). When Compared 
with women under 30 years, the adjusted odds ratio (95% confidence intervals, 
CI) of the following diagnoses in women over 35 were: unexplained infertility; 
1.8 (1.4-2.2), ovulatory dysfunction; 0.3 (0.3-0.4) and tubal factor; 2.2 (1.7-2.7), 
57.35 
 Moghadamet al.(2013), in  Epidemiology of Female Infertility studied 
Polycystic ovarian syndrome causes anovulation there by causing infertility in 
young women and it comprises of about 70% of anovulation infertility, and 
15.6% of primary infertilities.36 
 Wang et al. (2003) prospectively studied 518 newly married Chinese textile 
workers (20–34 years of age) trying to conceive. They recorded various factors 
like vaginal bleeding, sexual intercourse and collected daily first-morning urine 
specimens for up to 1 year or until the women become pregnant. Survival 
curves (Kaplan and Meier, 1958) were calculated for proportion of conceptions 
over number of menstrual cycles. In their study population, ,50% of women 
concieved in the first two cycles and .90% of women became pregnant in the 
first six cycles. According to their study the monthly fecundity varied between 
30 and 35%.32 
 Olooto ,WasiuEniola et al in, A review of Female Infertility; important 
etiological factors and management stated that Infertility is experienced by 10–
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15 % of couples worldwide. In Africa, itsprevalence is mainly high in sub-
Sahara ranging from 20% to 60% of the couples. It is estimated that 50-80% 
accounts for female factors and unexplained infertility and the male factor is 
responsible for 20-50% of the cause of infertility in different parts of Nigeria.38 
 Sule, Erigbali and Eroum et al.,(2008) in their study on Prevalence of  Female 
Infertility in a Southwestern Nigerian Community, concluded; Cases of 
infertility reported were caused by tubalfactor 39.5%, uterine factor30%, 
ovarian factor13% and malefactor 6.5% . Less common causes werepelvic 
inflammatory disease, 5.5%, cervical factor  3.0% and endometriosis 2.5%.37 
 SamihaMokhtar,  Hassan Ali Hassan, NehadMahdy et al., (2006) studied Risk 
Factors For Primary and Secondary Female Infertility in Alexandria: A Hospital 
Based Case Control Study; results were The highest reported population 
attributable risk percentages were: for primary infertility were as PCOS as 
19.4% followed by irregular mensteruation as 15.9% then STI as 7.9% and 
finally surgical operation as 4.6 %. The highest calculated PAR% in secondary 
infertility were irregular mensis as 19.2% followed by 15.4% for PCOS then 
14.1 % for STI and 6.5% for surgical operation.35 
 G.Sudha and K.S.N.Reddy  (2013) in their study on causes of female infertility  
concluded Maintaining a healthy lifestyle, getting regular checkups with the 
doctor and maintenance of normal body weight can avoid fertility problems. 
Fertility increases with identification and control of chronic diseases such as 
diabetes mellitus, thyroid disorders and tuberculosis.39 
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 MeraiyebuAjibola, Akintayo Christopher oloruntoba et al., in A study on effect 
of prolactin hormone on female infertility in National Hospital Abuja, Nigeria 
concluded that abnormal prolactin level has no effect in causing primary 
infertility. It has also been studied that abnormal prolactin level was also not the 
major cause for secondary infertility among the infertile female patients.40 
 M G R HULL,C M A GLAZENER et al., in Population study of causes, 
treatment, and outcome of infertility stated  that polycystic ovarian disease is 
the only major unsolved problem. Tubal damage (except operative sterilisation) 
is a major problem that occurs about 14% of cases and causesvery low chance 
of  successful pregnancy.41 
 Steinkeler et al., in Female Infertility: A  Systematic Approach  to Radiologic 
Imaging  and Diagnosis concluded that the genital causes of female infertility 
include abnormalities in tubes,  peritoneum, uterus, endometrium, cervix, and 
ovary. A multimodality imaging approach may be useful for identifying the 
cause of  infertility and helps in the management.42 
 AbhaMaheshwar et al., in Effect of female age on the diagnostic categories of 
infertility stated that  age is the prime factor that is associated with the 
prevalence of different causes of female infertility. Unexplained  and  tubal  
factor  infertility  is  common  in  women more than 35 years of age. The 
increased incidence of secondary infertility were mainly due to tubal factor, 
which is more likely due to previous ectopic pregnancy.43 
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 MARY ANNE ROSSING et al ., in OVARIAN TUMORS AMONG A 
GROUP OF INFERTILE WOMEN concluded that the risk of ovarian tumors 
are increased with prolonged use of clomiphene with ovulatory abnormalities.44 
 C.Augood et al., in Smoking and female infertility: a systematic review and 
meta-analysis, stated  that there is a significant rise in infertility among the 
smoking women comprising of   60% increase  in  the  risk  of  infertility  
among  cigarette  smokers.45 
 Izumi Imaoka et al., in  MRImaging of Disorders Associated with Female 
Infertility: Use in Diagnosis, Treatment, and Management concluded that MR 
imaging is a useful modality for routine work-ups in female with infertility. 
Pituitary adenoma can be diagnosed very effectively when patients are 
suspected to have disorder of the hypothalamic- pituitary-ovarian axis. The MR 
imaging helps in assessment of  the pelvic cavity in patients with infertility by 
evaluation of the functioning uterus and ovaries, differentiation of mullerian 
duct anomalies, and accurate noninvasive diagnosis of adenomyosis, 
leiomyoma, and  endometriosis.46 
 D.Meirow and J.G.Schenker et al., in The link between female infertility and 
cancer: epidemiology and possible aetiologiesstated  In many infertile patients, 
various factors like hormonal status, height, weight , BMI measurements and 
growth factors (composition and concentration) are considerably disturbed. 
Epidemiological, clinical and experimental studies have shown the association 
between these factorswith a higher cancer risk.47 
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 Willemsen et al. (1993), studied 12 female patients in whom a granulosa cell 
tumour was discovered after ovulation induction treatment with clomiphene 
citrate and/ or gonadotrophins, and has described about the prevelance of a 
granulosa cell tumour in this population was 0.23%, which is much higher than 
the incidence of granulose cell tumour in the female population as a whole. 
These data has not proved the existence of a causal relationship between 
ovulation induction treatments and the development of granulosa cell tumours. 
The possibility of such an association may exists and to confirm it further wide-
ranging investigations by registered authorities should be done.48 
 Ron et al. (1987) evaluated 2672 women who were treated for infertility 
(primary or secondary) between 1964 and 1974 with >31 600 patient years of 
follow-up. In his study the major infertility cause were found to be as hormonal 
(anovulation and menstrual irregularities) or other causes of infertility like male 
factors, mechanical, unexplained). In the infertile patients group there was a 
4.8-fold increased risk of endometrial carcinoma and a 10.3-fold increased risk 
of endometrial carcinoma  in infertile women with chronic anovulation.49 
 According to Rossing et al. (1994), the maximum risk of ovarian tumours 
associated with ovulatory abnormalities was seen in PCOS patients.50 
 B. R. Moller et al ., in Serological evidence that chlamydiae and  mycoplasmas 
are involved  in infertility of women stated  that antibody  to M. genitalium was 
found in about 25% of all female who came with complaints of infertility.51 
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 Conway et al,(1984) emphasize that pelvic inflammatory disease due to 
chlamydia  results in the tubal damage which increases the risk of ectopic 
pregnancy and infertility.52 
 Tyagi  et al., believe  that local changes in the endometrium along with the 
systemic effect are responsible for the menstrual  abnormalities.53 
 Marcus et al., concluded that IVF-ET offers the only realistic treatment for 
tuberculous infertility. Women with Tubercular endometritis and synechiae 
formation preclude the use of IVF. In such case the couples are best suited for 
adoption.54 
 Parikh et al., in Genital tuberculosis – a major pelvic factor that causes 
infertility in Indian women stated that genital tuberculosis is a chronic 
infectious disease which is one of the major etiologic factors that causes female 
tubal infertility due to peritubal adhesions and tubal block, especially in the 
India.55 
 Elizabeth A. Pritts et al., in Fibroids and infertility: an updated systematic 
review of the evidence concluded Fertility outcomes are reduced in women who 
had submucosal fibroids, and its removal had better outcome. Usually 
Subserosal fibroids  does not interfere with fertility outcomes, and its removal 
does not improve the outcome. Intramural fibroids are known to decrease 
fertility, but the results after its resection are unclear.56 
 Oliveira et al.,  stated that the anatomical distortion may reduce access to the 
tubes by ejaculated sperm if fibroids are located near the cervix or near the tubal 
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ostia,  , whereas the large corneal fibroids or lesions results in impairment of 
ovum retrieval by the tubes.57 
 Surreyet al.(2005) recently report IVF outcome in patients operated for 
submucosal fibroids. The pregnancy rate in operated patients and in the control 
group was 68 (69 /101) and 62% (900/1448), respectively (P-0.24). Overall, 
even if the available evidence is still scanty, previous myomectomy does not 
appear to negatively affect the chances of pregnancy in IVF cycles.58 
 Richards et al., stated  that fibroids usually interfere with the migration of 
sperms, ovum transport and implantation of embryo. The presence of 
submucosal fibroids causes local inflammation which may result in a hostile 
endometrial environment leading to the impairment of sperm transport and 
embryo implantation.59 
 Somigliana et al ., in Fibroids and female reproduction: a critical analysis of the 
evidence  stated that in IVF cycles, the pregnancy rate is decreased in patients 
with submucus or intramural fibroids but is not affected in the patients who 
have undergone myomectomy. Available evidence also suggests that 
submucosal, intramural and subserosal fibroids interfere with fertility in 
decreasing order of importance.60 
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5. MATERIALS AND METHODS: 
a. Study design: Non-Randomized cross sectional study                       
b. Study setting: Obstetrics &gynaecologyoutpatientdepartment , pathology  
department, SreeMookambika Institute of Medical Science. Kulasekharam. 
c. Duration of the study: One year 
d.Study group: One group 
e. Description of the group: women with history of  infertility attending OG 
outpatient department, SreeMookambika Institute of Medical Science 
Kulasekharam from 2014 to2015 taking in to consideration of inclusion and 
exclusion criteria. 
f. Sample size: 43 
g.Scientific basis of sample size used in the study: 4pq/d2 = 42.85 
  p= 70%, q=(100-p), d=20% of p             (Moghadamet al.(2013), in  
Epidemiology of Female Infertility studied Polycystic ovary syndrome causes 
infertility in young women and provides 70% of unovulation infertility, and 
15.6% of primary infertilities.16 
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  h. Inclusion criteria: 
1. Women attending  gynecology outpatient department with following criteria: 
                         - age 20 to 40   
                         -  married for >1 year and living with husband 
                         -  not using any contraception 
                          - Couples who fail to conceive following a previous pregnancy, 
in the   absence of contraception,breastfeeding or postpartum amenorrhoea for a 
period of two years 
i. Exclusion Criteria:   
                  1. Those who are not willing to participate 
                  2.      Women on In Vitro Fertilization (IVF) treatment 
j. Parameters to be studied:  
i.  Detailed history of the patient with general examination, height, weight, 
speculum examination,  basic blood investigations with TFT, Urine Routine and 
USG abdomen and pelvis 
      k. Methods /technique/instrument/reagent/ kit used to measure the 
quantitative parameters along with their manufacturing source details:  
Basic blood investigations with TFT, Urine Routine and USG abdomen and 
pelvis to be done (if the patient has never done any investigations). 
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          l. Procedure in detail:  Protocol will be submitted to Human Ethical 
Committee (HEC) for its approval. After getting approval from HEC, written 
informed consent will be obtained from the patient before enrolling them into 
study. 
                1. A detailed history to be taken ,Menstrual history, coital history, obstetric 
history,past medical history, family history, personalhistory, surgical history. 
                 2. A thorough general physical examination with reference to height, weight, 
pulse, blood pressure, temperature, respiratory rate were noted followed by 
Cardiovascular system, respiratory system, speculum examination, pelvic 
examination. 
                   3. Routine blood investigations, Blood sugar, TFT, USG abdomen and pelvis. 
s. Statistical methods of analysis: 
i) Significance level decided before starting of study: by calculating the 
statistical  parameters like mean, standard deviation. 
ii)  Statistical tests to be used for data analysis: Chi-Square test/ ODDS ratio 
iii) Software to be used for statistical analysis: All parameters will be entered 
in Microsoft Excel. Analysis will be done using SPSS software version 20.0 
(Trial version). 
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                                                     6.RESULTS: 
6.1 Assesment of demographic data  
Table-1 : Distribution of patients according to age  
Age No. of patients Percentage 
24 yrs - 30 yrs 25 58.1 
31 yrs - 35 yrs 15 34.9 
36 yrs - 40 yrs 3 7.0 
Total 43 100.0 
 
According to the above table maximum number of patients who came with 
complaints of infertility were in the age group between 24 – 30 years, that is 
58.1% (25/43) and 34.9%(15/43) were of 31 – 35 years. Only 7% (3/43) were in 
the age group between          36 – 40 years. 
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Figure -  7 : Distribution of percentage of patients according to age 
 
According to the above table maximum number of patients who came with 
complaints of infertility were in the age group between 24 – 30 years, that is 
58.1% (25/43) and 34.9%(15/43) were of 31 – 35 years. Only 7% (3/43) were in 
the age group between          36 – 40 years. 
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Table-2:Distribution of number of patients according to Socio economic 
status 
 
Socio economic status No. of patients Percentage 
Middle 2 4.7 
Upper middle 41 95.3 
Total 43 100.0 
 
Figure-  8 : Distribution of percentage of patients according to socio 
economic status 
 
Among the study population, majority of the women belonged to upper middle 
class , that is 95.3% (41/43) and only 4.7% (2/43) were of middle class. 
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6.2. Assesment of history 
 
Table-3 :Distribution of number of patients according to their years of 
marriage 
 
Married for yrs No. of patients Percentage 
<5 yrs 17 39.5 
5-10 yrs 22 51.2 
>10 yrs 4 9.3 
Total 43 100.0 
 
Figure- 9   :Distribution of percentage of patients according to their years 
of marriage 
 
 
 
Among the study 51.2%(22/43) were married for 5-10 years and 39.5%(17/43) 
were married for less than 5 years. Only 9.3%(4/43) were married for more than 
10 years. 
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Table-4:Distribution of number of patients according to Menstrual cycle 
 
 
Figure- 10  : Distribution of percentage of patients according to Menstrual 
cycle 
 
Among the study group 55.8%(24/43) had regular menstrual cycle and 
44.2%(19/43) had irregular menstrual cycle. 
 
 
Regular 
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Irregular 
44.2% 
Menstrual 
cycle No. of patients Percentage 
Regular 24 55.8 
Irregular 19 44.2 
Total 43 100.0 
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Table-5:Distribution of number of patients according to Dysmenorrhoea 
 
Dysmenorrho
ea No. of patients Percentage 
Present 14 32.6 
Absent 29 67.4 
Total 43 100.0 
 
Figure- 11  :Distribution of percentage of patients according to 
Dysmenorrhoea 
 
 
 
Among the study group only 32.6%(14/43) women had dysmenorrhoea and no 
history of any dysmenorrhoea in the remaining 67.4%(29/43) of women. 
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Table-6: Distribution of number of patients according to foul smelling 
Vaginal discharge 
Vaginal 
discharge No. of patients Percentage 
Present 13 30.2 
Absent 30 69.8 
Total 43 100.0 
 
Figure- 12  : Distribution of percentage of patients according to foul 
smelling Vaginal discharge 
 
In this study 30.2%(13/43) women had complaints of foul smelling vaginal 
discharge. Whereas the other 69.8%(30/43) had no such complaints. 
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Table-7 :Distributionof number of patients according to the Treatment for 
Infertility 
Treated for Infertility 
No. of 
patients 
Percentag
e 
Ovulation induction 16 37.2 
Laparoscopy 4 9.3 
None 23 53.5 
Total 43 100.0 
 
Among the 43 infertile women 37.2%(16/43) were on ovulation induction and 
9.3%(4/43) had underwent diagnostic laparoscopy. 53.5%(23/43) were not on 
any treatment. 
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Figure- 13 :Distribution of  percentage of patients according to the 
Treatment for Infertility 
 
Among the 43 infertile women 37.2%(16/43) were on ovulation induction and 
9.3%(4/43) had underwent diagnostic laparoscopy. 53.5%(23/43) were not on 
any treatment. 
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Table-8:Distribution of number of patients according to co- morbidities 
Co- marbidites No. of patients Percentage 
DM 7 16.3 
Hypothyroid 3 7.0 
TB 2 4.7 
None 31 72.1 
Total 43 100.0 
 
In our study 16.3%(7/43) were diabetic, 7%(3/43) were hypothyroid and 
4.7%(2/43) were known case of tuberculosis. Remaining 72.1%(31/43) were 
without any co-morbidities. 
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Figure-  14 :Distribution of percentageof patients according to co- 
morbidities 
 
 
 
In our study 16.3%(7/43) were diabetic, 7%(3/43) were hypothyroid and 
4.7%(2/43) were known case of tuberculosis. Remaining 72.1%(31/43) were 
without any co-morbidities. 
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Table-9:Distribution of number of patients according to Family H/O of 
Infertility 
Family H/O No. of patients Percentage 
Present 10 23.3 
Absent 33 76.7 
Total 43 100.0 
 
Figure-15 :Distribution of percentage of patients according to Family H/O 
of Infertility 
 
In our study , among 43 infertile women 23.3%(10/43) had family history of 
infertility and 76.7%(33/43) did not have any family history of infertility. 
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6.3.Assesment of general and vaginal examination : 
Table-10:Distribution of number of patients according to BMI 
 
 
Figure-  16 :Distribution of percentage of patients according to BMI 
 
In our study, majority of the women, about 46.5%(20/43) were of normal  BMI 
between 18.5-24.9kg/m2 , 41.9%(18/43) were overweight  with BMI 25-
29.9kg/m2and 11.6%(5/43) were obese with BMI more than 30kg/m2. 
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BMI No. of patients Percentage 
18.5-24.9 20 46.5 
25-29.9 18 41.9 
>30 5 11.6 
Total 43 100.0 
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Table-11:    Distribution of number of patients according to Pelvic                           
Examination  
 
Figure- 17 :Distribution of percentage of patients according to Pelvic 
Examination 
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Pelvic Examination No. of patients Percentage 
Normal 23 53.5 
Foul smelling vaginal discharge 12 27.9 
Fornices tender restricted mobility 4 9.3 
Bulky uterus 4 9.3 
Total 43 100.0 
65 
 
Among the study group, on per vaginal examination 27.9%(12/43) had foul 
smelling vaginal discharge , 9.3%(4/43) had forniceal tenderness and restrictd 
mobility of uterus, 9.3%(4/43) had bulky uterus. 
 
6.4. Assesment of radiological findings 
Table-12: Distribution of number of patients according to USG  
 
 
 
 
 
 
 
 
 
 
 
 
USG No. of patients Percentage 
Normal 14 32.6 
PCOD 21 48.8 
Fibroid 3 7.0 
Adenomyosis 1 2.3 
Chocolate cyst 4 9.3 
Total 43 100.0 
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Figure- 18:Distribution of percentage of patients according to USG 
 
 
Among 43 women in our study group 48.8%(21/43) had PCOD, 7%(3/43) had 
fibroid uterus, 2.3%(1/43) had adenomyosis, 9.3%(4/43) had endometriotic 
chocolate cyst and remaining 36.2%(14/43) patient’s USG were normal. 
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6.5.Assesment of  Hysteroscopic findings 
Table-13: Distribution of number of patients according to Hysteroscopy 
Hysteroscopy No. of patients Percentage 
Normal 38 88.4 
Tubal block 5 11.6 
Total 43 100.0 
 
Figure-  19 :Distribution of number of percentage according to 
Hysteroscopy 
 
In our study, among 43 infertile women the hystroscopic findings were normal 
in 88.4%(38/43), whereas 11.6%(5/43) had tubal block. 
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7.DISCUSSION 
In the present study, 43 women who came to OPD with complaints of Infertility 
were examined. They were also subjected to investigations like routine blood 
investigations, thyroid function test, ultrasound abdomen and pelvis and 
hysteroscopy to find out the cause for infertility. 
The study group comprised of women aged between 24 to 40 years. 
Abhamaheshwari et al in their study said that  Women over 35 years of age are 
nearly twice as likely to present with unexplained infertility. 61 
Based on the distribution of study population , according to socio economic 
status of women, 95.3% (41/43) of them were belonging to upper middle 
socioeconomic status.    F Grodstein et al stated that approximately 70% of 
infertile women in his study were belonging to relatively high socio economic 
status. 62 
About 51.2%(22/43) of study population were married for 5 – 10 years and 
suffering from infertility. 39.5%(17/43) were married for less than 5 years. Only 
9.3%(4/43) were married for more than 10 years. Karla L. Bretherick et al 
stated in their study that as the marietal age increases, incidence of infertility 
increases. 63 
Among the study population 55.8%(24/43) women had regular menstrual cycle 
and 44.2%(19/43)  women had irregular menstrual cycle. 32.6%(14/43) of 
women  had dysmenorrhoea.  
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In the present study 30.2%(13/43) women had complaints of foul smelling 
vaginal diacharge , suggestive of infection , this may be due to any local cause 
or pelvic infection. WESTROM et al in their study stated that about 28.6% of 
female infertility is mainly due to Pelvic Inflammatory Disease, which is a 
preventable cause if detected and treated early.65 
Among the study population 37.2%(16/43) women were on ovulation induction 
and 9.3%(4/43) had underwent laparoscopy. Others were not on any treatment.  
In our study group 16.3%(7/43) women were diabetic , 7%(3/43) women were 
known case of hypothyroid and 4.7%(2/43) women had tuberculosis and 
treated. George Schaefer et al  has stated that genital tract tuberculosis may 
exist without obvious clinical signs and symptoms, and may be the cause of 
infertility in 5% or more of women with infertility.67 
In the present study  23.3%(10/43) who came with complains of infertility had 
similar family history of infertility. 
In our study, majority of  the women, about 46.5%(20/43) were of normal  BMI 
between 18.5-24.9kg/m2 , 41.9%(18/43) were overweight  with BMI 25-
29.9kg/m2 and 11.6%(5/43) were obese with BMI more than 30kg/m2. B M 
Zaadstra et al in their study concluded that body fat distribution in women of 
reproductive age seems to have more impact on fertility than age.68 
On pelvic examination of all 43 women 27.9%(12/43) had foulsmelling vaginal 
discharge, which is suggestive of genital tract infection. 9.3%(4/43) had tender 
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fornices with restricted mobility. 9.3%(4/43)  had bulky uterus, suggestive of 
adenomyosis or fibroid uterus.  
According to ultrasonogram   7%(3/43) had fibroid uterus, 2.3% (1/43) had 
adenomyosis and 9.3%(4/43) had chocolate cyst. But majority of them were 
reported as PCOD 48.8%(21/43), which is almost half of the total study 
population. Adam H.Balen et al in their study stated that ,Although the 
ultrasound criteria for the diagnosis of polycystic ovaries have never been 
universally agreed, the characteristic features are accepted as being an increase 
in the size (volume) of the ovary due to a greater number of follicles and 
volume of stroma as compared with normal ovaries.70 
During hysteroscopic assessment for tubal patency among our study population, 
11.6%(5/43) had bilateral tubal block .Abraham Golan et al in their study 
concluded that  Hysteroscopy, a safe and rapid direct visualisation of the uterine 
cavity, is superior to HSG in the identification of intrauterine pathology. In 
view of the low positive predictive value and the low specificity of the HSG, we 
believe it should be replaced by the diagnostic hysteroscopy as a first line 
infertility investigation.71 
In our study among 43 women who were evaluated for infertility 48.8%  had 
PCOD  as the cause for infertility, followed by tubal block which was due to 
various causes like pelvic inflammatory disease, diabetes and tuberculosis and 
followed by fibroid uterus adenomyosis. 
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On the basis of study conducted among 43 women , various causes of female 
infertility are tabulated as follows: 
Table – 14: Percentage of causes of female infertility 
                                           
 
 
 
 
 
CAUSES OF INFERTILITY PERCENTAGE 
PCOD 41.8% 
PCOD with DM 6.9% 
TUBAL BLOCK 
 PID 
 DM 
 TUBERCULOSIS 
25.5% 
 11.6% 
 9.3% 
 4.6% 
FIBROID UTERUS 6.9% 
ENDOMETRIOSIS 9.3% 
ADENOMYOSIS 
UNEXPLAINED 
2.3% 
6.9% 
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8.CONCLUSION 
 Infertility is the major issue which has been increasimg in rate in this current 
era. 
 Female factors of infertility should be  evaluated thoroughly starting from the 
history , examination and investigations. 
 PCOD is the major cause of female infertility which is increasing in rate due to 
lifestyle changes. 
 PCOD is also easily treatable and the prognosis is good when compared to the 
other causes of infertility. 
 Next majorcause of female infertility is tubal block which is due to PID, DM 
and TB. 
 Endometriosis is also found in some female presenting with infertility. Outcome 
is poor in this group of  people as it is not completely treatable. 
 Very minimal population with infertility presents with fibroid uterus and 
adenomyosis 
 There is a category called Unexplained Infertility which is also known as 
idiopathic infertility, which includes the population whose cause for infertility is 
not known.  
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9.SUMMARY 
 This study was a Non-Randomized cross sectional study conducted in the 
department of obstetrics and gynaecology. 
 In this period 43 women who has attended the OPD for infertility were 
evaluated, examined and investigated to find out the cause for infertility. The 
results were analysed. 
 In our study majority of the women who presented with infertility were 
belonging to the age group between 24 – 30 years. 
 Majority of the women in our study group were belonging to upper middle 
socio-economic class. 
 Among 44.2%(19/43)  of women who had irregular menstrual cycle, majority of 
the women had PCOD and the others had pathology in uterus like fibroid , 
adenomyosis and endometriosis. 
 Among 30.2%(13/43) of women who presented with foul smelling vaginal 
discharge, 23.2%(10/43) had pelvic inflammatory disease. 
 In our study population of 43 women,  37.2%(16/43) was on ovulation 
induction and 9.3%(4/43) had underwent laparoscopy 
 Among the study population, About 16.3%(7/43) had diabetes mellitus, 
7%(3/43) had hypothyroid and 4.7%(2/43) were known case of tuberculosis and 
treated. All these co-morbidities are strongly associated with infertility. 
 Majority of  the women, about 46.5%(20/43) were of normal  BMI between 
18.5-24.9kg/m2 , 41.9%(18/43) were overweight  with BMI 25-29.9kg/m2 and 
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11.6%(5/43) were obese with BMI more than 30kg/m2. Obesity also plays a 
major role in causing infertility secondary to PCOD. 
 Among 9.3% (4/43) women who had tender fornices and restricted mobility on 
pelvic examination,4.6% (2/43) had PID and 4.6%(2/43) had endometrioses. 
 USG showed 48.8%(21/43) had PCOD, 7%(3/43) had fibroid uterus, 2.3% 
(1/43) had adenomyosis and 9.3%(4/43) had chocolate cyst. 
 Among 11.6%(5/43) of women who had tubal block on hysteroscopic 
evaluation, 9.3%(4/43) had PID and 2.3%(1/43) had diabetes mellitus. 
 According to our study PCOD is the major cause of female infertility (48.8%). 
 The other minor causes are tubal block due to PID, disbetes mellitus and 
Tuberculosis. 
 Uterine pathology like adenomyosis, fibroid uterus and endometriosis also play 
a minor role in infertility. 
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 On the basis of study conducted among 43 women , various causes of female 
infertility are tabulated as follows: 
 
 
 
 
  
CAUSES OF INFERTILITY PERCENTAGE 
PCOD 41.8% 
PCOD with DM 6.9% 
TUBAL BLOCK 
 PID 
 DM 
 TUBERCULOSIS 
25.5% 
 11.6% 
 9.3% 
 4.6% 
FIBROID UTERUS 6.9% 
ENDOMETRIOSIS 9.3% 
ADENOMYOSIS 
UNEXPLAINED 
2.3% 
6.9% 
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ANNEXURE – II 
ABBREVIATIONS 
ACTH    -   Adrenocorticotropic hormone 
BMI             -   Body Mass Index 
FSH             -   Follicular stimulating hormone 
GH              -    Growth hormone 
GnRH          -  Gonadotropin releasing hormone 
LHRH         -   Leutenizing hormone releasing hormone 
PCOD         -  Polycystic ovarian disease 
PCOS          -  Polycystic ovarian syndrome 
PID            -   pelvic inflammatory disease 
STD           -   Sexually transmitted disease 
WHO      -  World health organisation  
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ANNEXURE – III 
PROFORMA 
 
Name: 
Age    :               yrs 
OP No: 
Address: 
Occupation:      unemployed / employed / semi-skilled 
Married since: 
Primary / Secondary infertility:  
1. MENSTURAL HISTORY 
 
 Menarche:        yrs 
 
 Previous menstrual history: 
                                               Duration of cycle: 
                                   Number of pads changed: 
 
                                   Associated with Dysmenorrhoea: Spasmodic/Congestive: 
                    
                                   Passage of clots:               yes / no 
                                    
                                   Vaginal discharge:           yes / no 
 
                                   LMP: 
2. MARITAL HISTORY: 
                     
3. COITAL HISTORY: 
 
             H/O Dyspareunia:                                 yes / no 
 
             H/O Post Coital Bleeding:                    yes / no 
 
             H/O Urethral discharge in male partner       yes / no 
 
xiii 
 
 
4. PAST OBSTETRIC HISTORY             
                   Abortion:             No of pregnancies:             Ectopic:              Total Live: 
                   H/O Contraception:         yes / no 
 
5. HISTORY OF TREATMENT FOR INFERTILITY            yes / no 
 
6. PREVIOUS GYNAECOLOGICAL HISTORY 
 
7. MEDICAL HISTORY 
 
       DM                          yes / no               Endometriosis        yes / no 
       HT                           yes / no               PID                         yes / no 
       Tuberculosis            yes / no               HIV                        yes / no 
       Bronchial asthma     yes / no              STD                        yes / no 
 
8. SURGICAL HISTORY 
      
      Previous laparotomy / laparoscopy              yes / no 
 
9. FAMILY HISTORY 
 
       H/o  Infertility                  yes / no                           
                     
10. DRUG HISTORY 
 
           H/O Long term Medication              yes / no 
 
  EXAMINATION OF THE PATIENT: 
            GENERAL EXAMINATION: 
Height:     cms        Weight:      kg              BMI:          kg/m2     
 BP:           mm/Hg              PR:        /min 
Anemia                +  /  - 
Hirsuitism            +  /  - 
Acne                     +  /  - 
 
        
xiv 
 
  SYSTEMIC EXAMINATION: 
                CVS: 
                RS: 
               Abdomen: 
               Breasts: 
          PELVIC EXAMINATION: 
              Per Speculum: 
              Bimanual Examination: 
 
          INVESTIGATIONS: 
1. Blood routine 
2. Blood sugar 
3. Urine routine 
4. TFT 
5. Lipid profile 
6. HIV, VDRL, HBsAg 
7. Monteux test 
8. Chest Xray 
9. Blood Grouping & typing 
10.  PCR 
11. USG abdomen and pelvis 
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                                                            ANNEXURE - IV 
PARTICIPANTS CONSENT FORM 
 The details of the study have been explained to me in writing and the 
details have been fully explained to me. I am aware that the results of the study 
may not be directly beneficial to me but will help in the advancement of 
medical sciences. I confirm that I have understood the study and had the 
opportunity to ask questions. I understand that my participation in the study is 
voluntary and that I am free to withdraw at any time, without giving any reason, 
without the medical care that will normally be provided by the hospital being 
affected. I agree not to restrict the use of any data or results that arise from this 
study provided such a use is only for scientific purpose(s). I have been given an 
information sheet giving details of the study. I fully consent to participate in the 
study titled “A STUDY ON CAUSES OF FEMALE INFERTILITY” 
Serial no/Referance no: 
Name :       Address : 
 
 
Contact no :                                             Signature of the participant 
Witness 
1. 
2. 
 
Date : 
 Place : Kulasekharam. 
 
                       
                                           
s.no  Age  ed  Occu  S.E.  p/s  Marri Men dys  Vd  Tr  DM,TB
,THY 
P.h/o  F. 
h/o 
 
D. 
h/o 
ht  Wt  BMI  P/V  USG  Hys 
1  28  1  1  2  1  1  1  2  2  3  1  2  1  2  2  3  2  1  1  3 
2  25  1  1  2  1  1  2  1  2  3  4  2  2  2  3  2  1  1  2  1 
3  26  2  3  3  1  2 2 2 2 3 4 2 2  2 2 3 2 1 2 1
4  30  2  3  3  1  1  2  2  2  1  4  2  2  2  3  3  1  1  2  1 
5  32  3  3  3  1  2  2  2  1  2  1  2  2  2  2  3  2  2  1  3 
6  30  3  3  3  1  2 1 2 1 3 1 2 2  2 2 4 2 2 1 3
7  25  2  3  3  1  2  2  2  2  1  4  2  1  2  2  2  1  1  2  1 
8  32  3  3  3  1  1  2  1  2  3  2  2  2  2  2  2  1  4  3  1 
9  27  2  3  3  1  2  1  2  1  3  4  2  2  2  3  1  1  2  1  3 
10  31  3  3  3  1  2 1 2 2 1 4 2 1  2 2 2 1 2 2 1
11  24  2  3  3  1  1  1  2  2  1  4  2  2  2  1  2  2  1  2  1 
12  24  3  3  3  1  1  2  2  2  3  4  2  2  2  3  5  3  1  2  1 
13  30  3  3  3  1  1 1 1 2 1 4 2 2  2 2 1 1 4 3 1
14  32  3  3  3  1  2  2  1  2  1  4  2  2  2  2  2  2  3  5  1 
15  36  3  3  3  1  3  1  2  2  1  4  2  2  2  3  2  1  1  2  1 
16  32  3  3  3  1  2  2  2  2  1  4  2  2  2  2  2  2  1  2  1 
17  26  3  3  3  1  1 2 2 2 3 4 2 1  2 2 1 1 1 2 1
18  25  3  3  3  1  1  2  2  2  3  4  2  2  2  2  4  2  1  2  1 
19  32  3  3  3  1  2  2  1  2  1  4  2  2  2  1  1  1  1  2  1 
20  28  3  3  3  1  2 1 1 2 3 4 2 1  2 3 4 2 1 2 1
21  33  3  3  3  1  2 1 2 1 3 1 2 2  2 2 4 3 1 2 1
 
 
 
 
 
s.no 
age  edu  occ  SE  p/s 
inf 
marr M. 
cy 
dys  v.dis tr DM,TB,
THY 
P 
h/o 
F 
h/o 
D 
h/o
ht  wt  BMI  p/v  USG  Hys
22  35  3  3  3  1  3  1  2  1  1  1  2  2  2  1  2  2  1  2  1 
23  29  2  3  3  1 2 2 2 2 1 2 2  2 2 2 3 2 1 2 1
24  30  3  3  3  1  1  2  1  2  3  4  2  2  2  2  2  1  1  2  1 
25  32  3  3  3  1  2  2  1  2  3  2  2  2  2  2  3  1  1  2  1 
26  33  3  3  3  1  2  1  2  2  1  4  2  1  2  1  3  2  4  4  1 
27  39  3  3  3  1 3 1 2 2 1 4 2  2 2 1 2 2 3 5 1
28  28  3  3  3  1  1  1  1  2  3  4  2  2  2  2  1  1  3  5  1 
29  29  3  3  3  1  2  2  1  2  3  4  2  2  2  2  1  1  4  3  1 
30  35  3  3  3  1  2  1  2  1  3  3  2  2  2  1  1  1  2  1  1 
31  28  3  3  3  1 1 1 2 1 3 3 2  2 2 2 1 2 2 1 1
32  25  3  3  3  1  1  1  2  1  3  1  2  1  2  1  4  3  2  2  1 
33  26  3  3  3  1  1  1  2  1  3  4  2  1  2  2  1  1  2  1  1 
34  29  3  3  3  1  1  2  2  2  3  4  2  2  2  3  4  2  1  2  1 
35  35  3  3  3  1 2 2 1 2 2 4 2  2 2 2 1 1 1 2 1
36  27  3  3  3  1  2  1  1  2  3  4  2  2  2  3  4  2  3  5  1 
37  40  3  3  3  1  3  2  2  1  1  4  2  1  2  1  3  3  2  1  1 
38  29  3  3  3  1 1 1 1 1 3 4 2  2 2 2 2 1 2 1 1
39  32  3  3  3  1 2 1 2 1 1 4 2  2 2 1 3 2 2 1 1
40  30  3  3  3  1  2  1  1  1  1  1  2  1  2  2  2  1  2  1  3 
41  35  2  3  3  1  2  1  2  2  2  4  2  2  2  1  2  2  1  1  1 
42  28  3  3  3  1 1 1 2 2 2 4 2  2 2 1 3 3 1 1 1
43  33  2  3  3  1  2  1  2  2  3  4  2  2  2  2  1  1  1  1  1 
 
 
